---
schema_version: "secwatch.filing_event.v1"
accession: "0001490978-22-000011"
form_type: "8-K"
ticker: "SDGR"
cik: "0001490978"
company_name: "Schrodinger, Inc."
filed_at: "2022-11-03T23:59:59+00:00"
generated_at: "2026-06-22T08:49:11.981156+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Schrodinger Q3 rev $37M (+24% YoY); Lilly collab up to $425M; FY22 guide narrowed

## Summary
- Q3 total revenue $37.0M (+24% YoY); drug discovery $12.3M (+121%); software $24.7M (+2%)
- Net loss $39.9M vs $35.0M; cash $479M vs $513M at June 30, 2022
- Entered collaboration with Lilly; up to $425M in milestones plus tiered royalties
- Phase 1 trial of MALT1 inhibitor SGR-1505 open for patient enrollment
- FY22 total revenue guide narrowed to $167-175M; software rev lowered to $122-127M; drug discovery raised to $45-48M

## SEC filing metadata
- accession: 0001490978-22-000011
- form_type: 8-K
- ticker: SDGR
- cik: 0001490978
- company_name: Schrodinger, Inc.
- filed_at: 2022-11-03T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1490978/000149097822000011/0001490978-22-000011-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1490978/000149097822000011/sdgr-20221103.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001490978-22-000011
- JSON: https://secwatch.observer/filing/0001490978-22-000011.json
- Plain text: https://secwatch.observer/filing/0001490978-22-000011.txt

## Key facts
- Earnings Releases
  Schrodinger, Inc. updated its the fiscal year ending December 31, 2022 guidance (reaffirmed).
  - Period: the fiscal year ending December 31, 2022
  - Guidance: reaffirmed
  - Result: guidance update
  source text: Total revenue is now expected to range from $167 million to $175 million, compared to the prior expectation of $161 million to $181 million.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1490978/000149097822000011/0001490978-22-000011-index.htm
- Earnings Releases
  Schrodinger, Inc. reported financial results for the third quarter ended September 30, 2022.
  - Period: the third quarter ended September 30, 2022
  - Result: reported results
  source text: On November 3, 2022, Schrödinger, Inc. (the “Company”) issued a press release announcing its financial results for the third quarter ended September 30, 2022. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1490978/000149097822000011/0001490978-22-000011-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.